Evidence map›Paper›PMID 29271858›Full record

ArticleJournal of lower genital tract disease2018

Toll-Like Receptor Signaling Contributes to Proinflammatory Mediator Production in Localized Provoked Vulvodynia.

Megan L Falsetta, David C Foster, Collynn F Woeller, Stephen J Pollock, Adrienne D Bonham, Dorota Piekna-Przybylska, Sanjay B Maggirwar, Constantine G Haidaris, Richard P Phipps

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of lower genital tract disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05478746 (Effects of Flourish HEC Vaginal Care System on Reduction of Pain in Women With Localized Provoked Vulvodynia), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05478746 nacompletednot on this mapstarted 2022, after this paper: background citation

Effects of Flourish HEC Vaginal Care System on Reduction of Pain in Women With Localized Provoked Vulvodynia

TypeinterventionalSponsorVaginal Biome ScienceRan2022 to 2024Enrolled7ConditionsVulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar VestibulitisArmsBioNourish, a component of the Flourish HEC kit, Control - no intervention
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Inflammation, lipids, and pain in vulvar disease.Pharmacology & therapeutics · 2023
    Review
  6. Immune mechanisms in vulvodynia: key roles for mast cells and fibroblasts.Frontiers in cellular and infection microbiology · 2023
    Review
  7. Vulvodynia: Pain Management Strategies.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Vulvodynia.Nature reviews. Disease primers · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Megan L FalsettaDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
David C FosterDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Collynn F WoellerDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Stephen J PollockDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Adrienne D BonhamDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Dorota Piekna-PrzybylskaDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Sanjay B MaggirwarDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Constantine G HaidarisDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
Richard P PhippsDepartment of Environmental Medicine, University of Rochester, Rochester, NY.
University of Rochester · US

Funding

Localized Vulvodynia Pathogenesis: Fibroblast, Yeast, and MelanocortinR01HD069313 · NICHD · UNIVERSITY OF ROCHESTER · PI FOSTER, DAVID CHARLES, HAIDARIS, CONSTANTINE G · 2012 to 2016
$1.5M
NICHD NIH HHS R01 HD069313
6 · The paper itself

Abstract

objectivesLocalized provoked vulvodynia (LPV) afflicts approximately 8% of women in the United States and represents a huge financial, physical, and psychological burden. Women with LPV experience intense pain localized to the vulvar vestibule (area immediately surrounding vaginal opening). We have identified mechanisms involved in the development of LPV whereby vulvar fibroblasts respond to proinflammatory stimuli to perpetuate an inflammatory response that causes pain. However, these mechanisms are not fully elucidated. Therefore, we explored the role of toll-like receptors (TLRs), a class of innate immune receptors that rapidly respond to microbial assaults. MATERIALS AND

methodsTo determine whether TLRs are expressed by vulvar fibroblasts and whether these contribute to proinflammatory mediator production and pain in LPV, we examined TLR expression and innate immune responses in fibroblasts derived from painful vestibular regions compared with nonpainful external vulvar regions.

resultsHuman vulvar fibroblasts express functional TLRs that trigger production of inflammatory mediators associated with chronic pain. We focused on the TLR-7-imiquimod proinflammatory interaction, because imiquimod, a ligand of TLR-7, may exacerbate pain in women during treatment of human papillomavirus-associated disease.

conclusionsHuman vulvar fibroblasts express a broad spectrum of TLRs (a new finding). A significantly higher TLR-mediated proinflammatory response was observed in LPV case vestibular fibroblasts, and with respect to the imiquimod-TLR 7 interaction, development of chronic vestibular pain and inflammation may be a possible sequelae of treatment of vulvar human papillomavirus-associated disease. Suppressing enhanced TLR-associated innate immune responses to a spectrum of pathogen-associated molecular patterns may represent a new/effective therapeutic approach for vulvodynia.

Indexed as

Immunity, InnateSignal TransductionAminoquinolinesCells, CulturedFemaleFibroblastsGene Expression ProfilingHumansImiquimodInflammation MediatorsToll-Like Receptor 7VulvodyniaAminoquinolinesImiquimodInflammation MediatorsTLR7 protein, humanToll-Like Receptor 7

Identifiers

PMID29271858
PMCPMC5745044
OpenAlexW2781249430

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.